RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 36 filers reported holding RENEO PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,344,169 | +16.0% | 3,330,377 | 0.0% | 1.87% | +11.0% |
| Q2 2023 | $21,847,273 | +6.5% | 3,330,377 | -2.9% | 1.69% | +24.8% |
| Q1 2023 | $20,513,654 | +156.7% | 3,430,377 | 0.0% | 1.35% | +171.1% |
| Q4 2022 | $7,992,778 | -30.4% | 3,430,377 | 0.0% | 0.50% | -8.9% |
| Q3 2022 | $11,492,000 | +26.4% | 3,430,377 | 0.0% | 0.55% | +22.3% |
| Q2 2022 | $9,090,000 | -9.9% | 3,430,377 | 0.0% | 0.45% | -15.8% |
| Q1 2022 | $10,085,000 | -65.6% | 3,430,377 | 0.0% | 0.53% | -61.7% |
| Q4 2021 | $29,330,000 | +14.8% | 3,430,377 | 0.0% | 1.39% | +5.1% |
| Q3 2021 | $25,556,000 | -20.1% | 3,430,377 | 0.0% | 1.32% | -6.9% |
| Q2 2021 | $32,005,000 | – | 3,430,377 | – | 1.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,534,220 | $19,298,085 | 47.73% |
| NEA Management Company, LLC | 4,785,494 | $36,441,537 | 2.81% |
| Aisling Capital Management LP | 886,075 | $6,743,031 | 2.78% |
| Octagon Capital Advisors LP | 2,279,870 | $17,361,210 | 2.67% |
| Novo Holdings A/S | 3,330,377 | $25,344,169 | 1.87% |
| GREAT POINT PARTNERS LLC | 1,167,061 | $8,887,170 | 1.62% |
| Carlyle Group Inc. | 2,698,957 | $20,539,063 | 0.89% |
| Eventide Asset Management | 2,078,142 | $15,825,051 | 0.28% |
| Rock Springs Capital Management LP | 1,143,185 | $8,705,354 | 0.23% |
| First Light Asset Management, LLC | 272,317 | $2,073,694 | 0.20% |